NCT04694677

Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy.

Safety of Tranexamic Acid Versus Misoprostol in Reducing Blood Loss in Myomectomy.

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Aljazeera Hospital · Academic / Other
• Sex: Female
• Age: 20 Years – 50 Years
• Healthy volunteers: Accepted

Summary

Uterine leiomyomas (fibroids) are the most common benign tumors among women . Fibroids are found in approximately 15% to 30% of women in the reproductive age group

Detailed description

Although most of them are asymptomatic, 20-50% of fibroids may cause problems such as heavy menstrual bleeding, anemia, pelvic pain, pressure symptoms from extrinsic compression of the colorectal and urinary tract, infertility, and recurrent pregnancy losses, where surgical intervention is often indicated

Conditions

• Myoma

Interventions

Type	Name	Description
DRUG	women receiving tranexamic acid	women receiving tranexamic acid during myomectomy
DRUG	women receiving misoprostol	women receiving misoprostol in myomectomy

Timeline

• Start date: 2021-01-10
• Primary completion: 2021-08-15
• Completion: 2021-09-10
• First posted: 2021-01-05
• Last updated: 2021-01-05

Locations

1 site across 1 country: Egypt